VIVO Ventures Vii, LLC, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 3,814,953 shares at $11.00 ($5.0M) on 2015-10-13, disclosed to the SEC on 2015-10-13.
Open-market purchase of $5.0M ACRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,360,408 | $0 | 0.0% |
| 2 | $11.00 | 9,695 | $107K | 2.1% |
| 3 | $11.00 | 444,850 | $4.9M | 97.9% |
| Total | $1.31 avg | 3,814,953 | $5.0M | 100% |
| Filing → |
| CDXS | SELL | 2016-08-17 | $738K | — | Filing → |
| CDXS | SELL | 2016-08-05 | $549K | — | Filing → |
| MEIP | SELL | 2015-11-09 | $720K | — | Filing → |